Pharmafile Logo

News and Press Releases

Tilray Medical Launches Tilray Craft: Introducing High THC, High Terpene Genetics to the German Medical Cannabis Market

11 March 2025 -- Neumünster, Germany -- Tilray Medical, a division of Tilray Brands, Inc and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare...

Category: Other, Pharmaceutical
Posted: March 11, 2025

Tilray Medical
info@tilraymedical.com

Cymphony is urgently advocating for improved communication to meet the rapidly growing demand from Gen Z and Millennial patients

Now more than ever, patients are seeking timely and efficient ways to communicate with their healthcare providers 20 January 2025 -- Crewe, UK -- Given the recent uptick in private...

Category: Logistics, Other, Pharmaceutical
Posted: January 20, 2025

Cymphony
enquiries@cymphony.co.uk

TekniPlex Healthcare Becomes First to Introduce Medical-grade, ISCC PLUS-certified Bio-based PVC Compounds Equivalent to Conventional PVC

Company’s bio-based compounds are a drop-in replacement for a variety of injection molded or extruded medical-grade PVC compounds utilized in tubing, films, components and other applications. 3 October 2024 –Wayne,...

Category: BioManufacturing, Manufacturing and Packing
Posted: October 16, 2024

TekniPlex Healthcare
Industrielaan 37 B-9320 Erembodegem Belgium Tel: +32 (0)53 650711 VAT 0425.537.515

atai Life Sciences Announces Update on Beckley Psytech’s phase 1/2a Trial of ELE-101 (IV Psilocin) for Major Depressive Disorder, with Initial Results from phase 1 and First Patients Dosed in phase 2a

ELE-101 is a patent-protected, synthetic formulation of psilocin, designed to offer the therapeutic benefits of psilocybin in a more consistent, controllable and shorter treatment paradigm of approximately two hours The...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: June 21, 2024

Beckley Psytech
info@beckleypsytech.com
Beckley Park Beckley OXFORD, OX3 9SY United Kingdom

Numinus Wellness Announces Strategic Acquisition of MedBright AI

Plans name change to "Numinus Intelligence" leveraging its current revenue-generating operations to AI-enable mental health clinics across the US The strategic combination merges MedBright's AI-enabled clinical solution capabilities with Numinus'...

Category: Clinical Trials, Other, Pharmaceutical
Posted: June 20, 2024

Numinus

Lyphe and Gro-Vida Announce Partnership to Enhance Medical Cannabis Access

13 June 2024 -- London, UK -- Lyphe Clinic is thrilled to announce its partnership with Gro-Vida, a licensed medical cannabis cultivar. Lyphe Clinic is a leading medical cannabis clinic based...

Category: Biotechnology, Other, Pharmaceutical
Posted: June 13, 2024

Lyphe
info@lyphe.com
10 Harley St, London W1G 9PF

First participant dosed in research study investigating the effects of BPL-003, a novel formulation of 5-MeO-DMT, on the human brain

The study is the first of its kind to assess the effects of 5-MeO-DMT in the human brain and will investigate the neurophysiological effects of BPL-003, Beckley Psytech’s novel synthetic...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: June 3, 2024

Beckley Psytech
info@beckleypsytech.com
Beckley Park Beckley OXFORD, OX3 9SY United Kingdom

Lykos Therapeutics Appoints Finance Veteran Scott Giacobello to the Board of Directors

30 May 2024 -- California, US -- Lykos Therapeutics, a company dedicated to transforming mental healthcare, announced the appointment of finance veteran Scott Giacobello to the company's Board of Directors, effective immediately. A...

Category: Biotechnology, Clinical Trials, Other
Posted: May 30, 2024

Lykos Therapeutics
media@lykospbc.com 
3141 Stevens Creek Blvd Suite 40547 San Jose, CA 95117